Cantor Fitzgerald, L. P. Sellas Life Sciences Group, Inc. Transaction History
Cantor Fitzgerald, L. P.
- $697 Million
- Q2 2024
Shares
1 transactions
Others Institutions Holding SLS
# of Institutions
37Shares Held
4.37MCall Options Held
3.28MPut Options Held
56.3K-
Vanguard Group Inc Valley Forge, PA1.79MShares$2.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA517KShares$651,4300.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$542,2630.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$388,6673.71% of portfolio
-
Opus Capital Group, LLC221KShares$278,4600.04% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $25.9M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...